Incyte to Present at Upcoming Investor Conferences
Incyte to Present at Upcoming Investor Conferences
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of November:
- Wolfe Research Healthcare Conference on Tuesday, November 10, 2026 at 10:00 am (EST)
- Jefferies Global Healthcare Conference on Tuesday, November 17, 2026 at 9:00 am (GMT)
- UBS Global Biopharma Conference on Tuesday, November 17, 2026 at 1:20 pm (GMT)
The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
About Incyte
Incyte is redefining what’s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established portfolio of first-in-class medicines and an extensive portfolio of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation and Autoimmunity.
To learn more, visit Incyte.com and Investor.Incyte.com. Follow us on social media: LinkedIn, X, and Instagram.
Incyte Contacts
Media
media@incyte.com
Investors
ir@incyte.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20261104350871/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
3 of the Best Dividend Stocks to Own
The 10 Best Companies to Invest in Now
This Once-Hot AI Stock Now Looks Deeply Undervalued
United States